Symposium on Retinal Innovation

Download IconDownload Print IconPrint

Symposium on Retinal Innovation

Speaking Engagement
A full-day event bringing together world leaders of translational research in drug development, regenerative therapies, gene replacement and other treatments for retinal degenerative diseases and AMD with leaders from the life sciences investment world.

WilmerHale Partner David Redlick will moderate a panel titled “Pharma Collaborations and Alliances.”

Read More About the Event

Speakers

You May Be Interested In

AI & Financial Services – Part Two

April 16, 2024
Webinar

28th Annual Compliance Institute

April 16, 2024
Speaking Engagement

A Look Behind the Curtain – Being an Arbitrator or Tribunal Secretary in Turkish and Swiss Arbitrations

April 17, 2024
Speaking Engagement
View all Events

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel